These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 32122660

  • 1. The use of LCP-Tacrolimus (Envarsus XR) in simultaneous pancreas and kidney (SPK) transplant recipients.
    Torabi J, Konicki A, Rocca JP, Ajaimy M, Campbell A, Azzi Y, Pynadath C, Liriano-Ward L, Akalin E, Kinkhabwala M, Graham JA.
    Am J Surg; 2020 Apr; 219(4):583-586. PubMed ID: 32122660
    [Abstract] [Full Text] [Related]

  • 2. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
    Rostaing L, Bunnapradist S, Grinyó JM, Ciechanowski K, Denny JE, Silva HT, Budde K, Envarsus Study Group.
    Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
    [Abstract] [Full Text] [Related]

  • 3. LCP-Tacrolimus Extended-Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients.
    Bae EK, Chandran MM, Everitt MD, Benz E, Bock M.
    Clin Transplant; 2024 Aug; 38(8):e15417. PubMed ID: 39087462
    [Abstract] [Full Text] [Related]

  • 4. Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial.
    Suwelack B, Bunnapradist S, Meier-Kriesche U, Stevens DR, Procaccianti C, Morganti R, Budde K.
    Ann Transplant; 2020 Jul 28; 25():e923278. PubMed ID: 32719307
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial.
    Faravardeh A, Akkina S, Villicana R, Guerra G, Moten MA, Meier-Kriesche U, Stevens DR, Patel SJ, Bunnapradist S.
    Ann Transplant; 2021 Apr 16; 26():e929535. PubMed ID: 33859155
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.
    Trofe-Clark J, Brennan DC, West-Thielke P, Milone MC, Lim MA, Neubauer R, Nigro V, Bloom RD.
    Am J Kidney Dis; 2018 Mar 16; 71(3):315-326. PubMed ID: 29162334
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of once-daily vs twice-daily tacrolimus among Hispanic and Black kidney transplant recipients.
    Hurwitz JT, Grizzle AJ, Tyler CS, Zapata LV, Malone DC.
    J Manag Care Spec Pharm; 2021 Jul 16; 27(7):948-960. PubMed ID: 34185556
    [Abstract] [Full Text] [Related]

  • 12. The use of once-daily LCP-Tacrolimus with adolescent and young adult solid organ transplant recipients.
    Householder S, Ramakrishnan A, Chen JK, Gorsch L, Tsapepas D, Lobritto S, Rundle A, Vittorio JM.
    Pediatr Transplant; 2024 Jun 16; 28(4):e14777. PubMed ID: 38702932
    [Abstract] [Full Text] [Related]

  • 13. Extended-release tacrolimus dosing and outcomes in pediatric and young adult transplant recipients - A single-center experience.
    Huang X, Hapgood K, Allan K, Pruette C, Goswami E.
    Pediatr Transplant; 2024 Feb 16; 28(1):e14611. PubMed ID: 37735900
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups.
    Bunnapradist S, Rostaing L, Alloway RR, West-Thielke P, Denny J, Mulgaonkar S, Budde K.
    Transpl Int; 2016 May 16; 29(5):603-11. PubMed ID: 26953629
    [Abstract] [Full Text] [Related]

  • 16. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 16; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 17. Three-year outcomes of de novo tacrolimus extended-release tablets (LCPT) compared to twice-daily tacrolimus in adult heart transplantation.
    Alam A, van Zyl JS, Patel R, Jamil AK, Felius J, Carey SA, Gottlieb RL, Guerrero-Miranda CY, Kale P, Hall SA, Sam T.
    Transpl Immunol; 2024 Apr 16; 83():102009. PubMed ID: 38325525
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of Tacrolimus Concentrations and Clinical Outcomes Between Extended and Immediate Release Formulations in Kidney Transplant.
    Naguib H, Katz-Greenberg G, Harris M, Gommer J, Yang LZ, Erkanli A, Byrns J.
    J Pharm Pract; 2024 Dec 16; 37(6):1283-1290. PubMed ID: 38683344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.